News from elevation pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 03, 2012, 01:00 ET

Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress

 Elevation Pharmaceuticals, Inc. today presented positive efficacy and safety results from the GOLDEN-1 study – a Phase 2b study...

May 16, 2012, 08:00 ET

Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Elevation Pharmaceuticals, Inc., a pharmaceutical company focused on the development of new aerosol therapies for patients with respiratory...

Jan 04, 2012, 07:00 ET

Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy

 Elevation Pharmaceuticals, Inc. announced today the closing of a $30 million Series B financing, led by new investor Novo Ventures, to fund...

Sep 26, 2011, 08:00 ET

Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory...

Sep 26, 2011, 08:00 ET

Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory...

Jan 21, 2010, 08:00 ET

Elevation Pharmaceuticals Raises $30 Million in Series A Financing

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory...